Activation of blood coagulation factor VIIa with cleaved tissue factor extracellular domain and crystallization of the active complex

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Proteins: Structure, Function, and Bioinformatics

• Publication date

  1995-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/prot.340220412PMID 7479715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.

  1994cited by this paper
• Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain.

  1994cited by this paper
• Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis.

  1994cited by this paper
• Mass spectrometric analysis of human soluble catechol O-methyltransferase expressed in Escherichia coli. Identification of a product of ribosomal frameshifting and of reactive cysteines involved in S-adenosyl-L-methionine binding.

  1994cited by this paper
• Key ligand interface residues in tissue factor contribute independently to factor VIIa binding.

  1994cited by this paper
• Crystal structure of the extracellular region of human tissue factor

  1994cited by this paper
• A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries.

  1994cited by this paper
• Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site.

  1994cited by this paper
• Crystal structure of the extracellular region of human tissue factor

  1994cited by this paper
• Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

  1993cited by this paper
• Crystallization and preliminary X-ray analysis of human tissue factor extracellular domain.

  1993cited by this paper
• Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides.

  1993cited by this paper
• Initiation and regulation of tissue factor-dependent blood coagulation.

  1992cited by this paper
• Mass spectrometry of peptides and proteins.

  1992cited by this paper
• Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis.

  1992cited by this paper
• Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex.

  1992cited by this paper
• Sparse matrix sampling: a screening method for crystallization of proteins

  1991cited by this paper
• Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.

  1991cited by this paper
• The coagulation cascade: initiation, maintenance, and regulation.

  1991cited by this paper
• Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa.

  1991cited by this paper
• Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

  1991cited by this paper
• Primary sequence information from intact proteins by electrospray ionization tandem mass spectrometry.

  1990cited by this paper
• Structural design and molecular evolution of a cytokine receptor superfamily.

  1990cited by this paper
• Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.

  1990cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• Tissue factor and hemostasis.

  1988cited by this paper
• Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells.

  1988cited by this paper
• Evaluation of Single-Crystal X-ray Diffraction Data from a Position-Sensitive Detector

  1988cited by this paper
• Ion spray interface for combined liquid chromatography/atmospheric pressure ionization mass spectrometry

  1987cited by this paper
• Characterization by tandem mass spectrometry of structural modifications in proteins.

  1987cited by this paper
• An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage.

  1986cited by this paper
• Preparation and Analysis of Protein Crystals

  1983cited by this paper

• Nonstandard Factor VIIa Binding Mode Reveals S1 Pocket Plasticity in Trypsin‐Like Proteases

  2026influential citation
• A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders

  2024cites this paper
• Design and synthesis of peptidomimetic factor VIIa inhibitors.

  2010cites this paper
• Protein engineering.

  2007cites this paper
• Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors.

  2005cites this paper
• Structure of human factor VIIa/tissue factor in complex with a peptide-mimetic inhibitor: high selectivity against thrombin by introducing two charged groups in P2 and P4.

  2005influential citation
• Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.

  2005cites this paper
• Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor.

  2005cites this paper
• Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor.

  2004cites this paper
• Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition.

  2004cites this paper
• Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).

  2004cites this paper
• Design, synthesis, and structure-activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitors.

  2003cites this paper
• The protein as a variable in protein crystallization.

  2003cites this paper
• Predicted solution structure of zymogen human coagulation FVII

  2002cites this paper
• Inhibitors of Tissue Factor/Factor VIIa

  1999cites this paper
• Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.

  1999cites this paper
• Dynamic character of the complex of human blood coagulation factor VIIa with the extracellular domain of human tissue factor: a normal mode analysis

  1999cites this paper
• Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association.

  1999cites this paper
• Topological Studies of the Amino Terminal Modules of Vitamin K-dependent Protein S Using Monoclonal Antibody Epitope Mapping and Molecular Modeling

  1998cites this paper
• Limited proteolysis of a trypanosomal hypoxanthine phosphoribosyltransferase yields crystals that diffract X-rays to near atomic resolution.

  1998cites this paper
• Molecular and structural advances in tissue factor-dependent coagulation.

  1997cites this paper
• The Factor Vlla / Tissue Factor Complex

  1997cites this paper
• Molecular and Structural Tissue Factor-Dependent

  1997cites this paper
• The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

  1996cites this paper
• Mass spectrometry.

  1996cites this paper
• Initiation of blood coagulation: the tissue factor/factor VIIa complex.

  1996cites this paper